Table 5: Changes in the ALBI and CONUT scores at baseline, when starting and discontinuing lenvatinib in the follow-up group.
|
Parameter |
Baseline |
LEN stop |
After follow up |
|
ALBI score |
−2.03±0.74 |
−1.61±0.48 |
−1.57±1.14 |
|
CONUT score |
4.14±3.44 |
5.37±3.46 |
6.29±4.39 |
Parameter are described as mean ± SD at baseline, LEN stop and after follow up.
ALBI: Albumin-Bilirubin; CONUT: Controlling Nutritional Status; LEN: Lenvatinib.